Davis's Drug Guide
Amabelz 0.5/0.1
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Amabelz 0.5/0.1." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2025. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110515/all/Amabelz_0_5_0_1.
Vallerand AHA, Sanoski CAC, . Amabelz 0.5/0.1. Davis's Drug Guide. F.A. Davis Company; 2025. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110515/all/Amabelz_0_5_0_1. Accessed January 17, 2025.
Vallerand, A. H., Sanoski, C. A., & , (2025). Amabelz 0.5/0.1. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110515/all/Amabelz_0_5_0_1
Vallerand AHA, Sanoski CAC, . Amabelz 0.5/0.1 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2025. [cited 2025 January 17]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110515/all/Amabelz_0_5_0_1.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Amabelz 0.5/0.1
ID - 110515
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - ,,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110515/all/Amabelz_0_5_0_1
PB - F.A. Davis Company
ET - 19
DB - Medicine Central
DP - Unbound Medicine
ER -
